• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS PASCAL PRECISION; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS PASCAL PRECISION; MITRAL VALVE REPAIR DEVICES Back to Search Results
Model Number 20000ISM
Device Problems Off-Label Use (1494); Difficult to Advance (2920); Mechanical Jam (2983)
Patient Problem Rupture (2208)
Event Date 02/06/2023
Event Type  Injury  
Manufacturer Narrative
The event is captured by edwards lifesciences under complaint #: (b)(4).Outcomes attributed to adverse event: other serious- tissue damage.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.It should be noted, the device was implanted in the tricuspid position.At this time, the pascal precision transcatheter valve repair system is only indicated for the native mitral valve, addressing degenerative mitral regurgitation.Therefore, deployment in the tricuspid position is considered off-label.
 
Event Description
Edwards received notification of a pascal in tricuspid position where while implanting the 3rd pascal device, the echo showed that gs was accidently pulled back into ivc while retracting implant system number two.Gs was unflexed and advanced into ra again at level of tip of the ridge.There was steering down of third device under echo and fluoro control.While trying to maneuver to posterior septal position several times it entangled with lead in ra and rv or first ace implant.This was solved each time by elongation and retraction in ra.During these attempts at least three times the ic steered into cs- followed by immediate correction.Last correction of the entanglement in rv, echo noticed that system was stuck in ra at the height of the ridge.The device was in elongated position clasp up.The clasp was started to advance and it seemed that device was attached with a structure at one of the retention elements.Gentle movement of clasp was performed, rotation of implant catheter to see if this freed the device, gentle opening and closing and retracting and advancing.First nothing happened but then the device jumped, and hcp said he could turn ic 360 degrees but device still stuck at some structure (chiari network).Clasp was then no longer movable.Hcp then decided to retract is into gs and bail out with knowing that the structure the device was attached to would rupture.There was slow controlled pulling back of is into gs.Everything was removed within the gs and decision was made to stop the procedure.Final result was tr 4.Patient was stable.Other possible solutions need to be found to treat the residual tr.
 
Event Description
After image evaluation review, there appeared to be device interaction with anatomy/damage to anatomy of the 3rd ace device during device repositioning in the right atria in the procedural tee.There were two pascal ace devices deployed.The second ace device appeared to be in a stable position.The 3rd ace device appeared successfully bailed out.Final residual tr appeared semi-quantitatively, 3 - severe.
 
Manufacturer Narrative
It should be noted, the device was implanted in the tricuspid position.At this time, the pascal precision transcatheter valve repair system is only indicated for the native mitral valve in the us, addressing degenerative mitral regurgitation.But, it is approved for both tricuspid and mitral spaces in the region where the procedure was performed.Therefore, deployment in the tricuspid position will not be considered off-label in this case.
 
Manufacturer Narrative
The following sections have been added/updated/corrected: b4, d4, g3, g6, h2, h3, h4, h6 and h10.The complaint for unable to elongate implant to reposition/implant caught on anatomy was confirmed with objective evidence.Although the imaging evaluation did not observe the entanglement event or resulting bailout, a sample of tissue was visibly identified on the returned device.This tissue sample confirms the suspected entanglement event.Per the complaint information, the device was repositioned into the ra in the elongated position with the clasps up, which was aligned with the training manual instructions for repositioning into the ra.It is likely that a combination of the following factors led to this complaint event: presence of a pacemaker lead, eustachean ridge, 2 previous devices, and inadequate imaging.No manufacturing non-conformities were identified through this investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS PASCAL PRECISION
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
cassandra cook
1 edwards way
irvine, CA 92614
5743778277
MDR Report Key16464593
MDR Text Key310489139
Report Number2015691-2023-11190
Device Sequence Number1
Product Code NKM
UDI-Device Identifier00690103213324
UDI-Public(01)00690103213324(17)240105
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P220003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/05/2024
Device Model Number20000ISM
Device Catalogue Number20000ISMA
Device Lot Number10396751
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/27/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/06/2023
Initial Date FDA Received03/01/2023
Supplement Dates Manufacturer Received03/24/2023
05/04/2023
Supplement Dates FDA Received03/29/2023
05/08/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
-
-